Posted in | News | Biofuels

CleanTech Biofuels Passes First Milestone in Producing Ethanol from Cellulose

CleanTech Biofuels, Inc. announces that it has fulfilled its first milestone pursuant to its exclusive worldwide sublicense agreement for technology developed at the University of California, Berkeley for converting cellulose to ethanol.

Under the License Agreement, CleanTech is required to make payments to HFTA upon meeting certain development milestones for validation and commercialization of the technology. The first milestone, which was recently met, required that CleanTech satisfactorily test the technology using equipment developed at the University of California, Berkeley and subsequently purchased by CleanTech, to generate fermentable sugars from municipal solid waste at efficiencies satisfactory to CleanTech.

The patented technology, initially developed and tested at the University of California, Berkeley, utilizes nitric acid for hydrolyzing cellulosic material, rather than sulfuric or hydrochloric acid, for the production of ethanol and other fuels from biomass in municipal solid waste. Sulfuric or hydrochloric acid is typically used in the industry for hydrolyzing biomass; however, CleanTech believes that nitric acid hydrolysis represents the cutting edge of current technology in the cellulosic ethanol industry. CleanTech also obtained a nonexclusive worldwide license to use the technology for all other feedstocks for producing ethanol.

The licensed technology is described in U.S. Patents No. 5221357, 5366558, 5536325, 5628830, and 6019900. The sublicense agreement is with HFTA, a company formed by the developers of the technology.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.